CAREFUSION combines proven clinical technologies with actionable intelligence to improve patient care.
The company’s employees are focused on developing and bringing to market, solutions to today’s major healthcare challenges, for example healthcare-associated infections (HCAIs). The CareFusion infection prevention mission is to deliver clinically differentiated evidence-based products and services that support the global effort to reduce HCAIs. ChloraPrep is illustrative of this focus – the only 2% Chlorhexidine based product licensed for cutaneous antisepsis prior to medical and surgical invasive procedures. This allows healthcare professionals to comply with evidence-based guidelines and recognised best practice for prevention of HCAIs.
